Systemic Lupus Erythematosus
📧 Sign up to get email alerts when something new happens for Systemic Lupus Erythematosus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-02-25Clinical Trial Update: Fibroblast Growth Factor 21 in Systemic Lupus Erythematosus
A ClinicalTrials.gov listing describes a study evaluating Fibroblast Growth Factor 21 in systemic lupus erythematosus. The trial is currentl…
-
CLINICAL_TRIALS research · 2025-02-21Clinical Trial Update: A Study of SCTB35 in Patients with Systemic Lupus Erythematosus [Phase 1, Phase 2]
Clinical trial update for SCTB35 in patients with systemic lupus erythematosus, currently recruiting in Phase 1/Phase 2.
-
CLINICAL_TRIALS research · 2025-02-20Clinical Trial Update: Predictors of Bone Mineral Density in Lupus Nephritis Activity
Assiut University is conducting a clinical trial to identify predictors of bone mineral density in patients with lupus nephritis activity; t…
-
CLINICAL_TRIALS research · 2025-02-20Clinical Trial Update: A Study in Participants With Mild-to-moderate Systemic Lupus Erythematosus [Phase 1]
A Phase 1 clinical trial update for a treatment in patients with mild-to-moderate systemic lupus erythematosus, currently active and not rec…
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: Safety and Efficacy of Universal CAR-T Cells (UWD-CD19) Combined with Immunosuppressants in the Treatment of Refractory Autoimmune Diseases [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating safety and efficacy of universal CD19 CAR-T cells (UWD-CD19) with immunosuppressants for refractory auto…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: Exploratory Clinical Study of CNCT19 Anti CD19 Cell Therapy in the Treatment of Refractory Autoimmune Diseases [EARLY_Phase 1]
An early-phase exploratory study of CNCT19 anti-CD19 cell therapy for refractory systemic lupus erythematosus is currently recruiting.
-
CLINICAL_TRIALS research · 2025-02-04Clinical Trial Update: Systemic Lupus Erythematosus Within the Framework of the Multidisciplinary Consultation [NA]
A recruiting clinical trial investigating systemic lupus erythematosus is ongoing under a multidisciplinary consultation framework, sponsore…
-
CLINICAL_TRIALS research · 2025-02-04Clinical Trial Update: Evaluating Mental Health Challenges in Juvenile Lupus Erythematosus and Their Caregivers
This clinical trial aims to evaluate mental health challenges in children with juvenile systemic lupus erythematosus and assess the impact o…
-
CLINICAL_TRIALS research · 2025-01-29Clinical Trial Update: Establishing the Salience of Type 1 Interferon Pathway Blockade in the Central Mechanisms of SLE Related Fatigue
This clinical trial update investigates the role of blocking Type I interferon signaling in the central mechanisms underlying fatigue in sys…
-
CLINICAL_TRIALS research · 2025-01-28Clinical Trial Update: Systemic Immune Inflammatory Index in Systemic Lupus Erythematosus
A clinical trial investigating the Systemic Immune Inflammatory Index in patients with Systemic Lupus Erythematosus and Lupus Nephritis is c…
-
CLINICAL_TRIALS research · 2025-01-23Clinical Trial Update: 3TR (Taxonomy, Treatment, Targets and Remission) Systemic Lupus Erythematosus Study Protocol 2
The document describes the 3TR Study Protocol for Systemic Lupus Erythematosus, an active non-recruiting clinical trial sponsored by Univers…
-
CLINICAL_TRIALS research · 2025-01-23Clinical Trial Update: 3TR (Taxonomy, Treatment, Targets and Remission) Systemic Lupus Erithematosus Study Protocol [Phase 3]
Phase 3 study protocol for a Systemic Lupus Erythematosus trial investigating taxonomy, treatment targets, and remission.
-
CLINICAL_TRIALS research · 2025-01-20Clinical Trial Update: Biomarkers in Inflammatory Rheumatic Diseases Diagnosis
A clinical trial update from Universidade Nova de Lisboa focusing on biomarkers for diagnosing inflammatory rheumatic diseases, currently re…
-
CLINICAL_TRIALS research · 2025-01-10Clinical Trial Update: A Study of LCAR-AIO in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus [EARLY_Phase 1]
An early-phase 1 clinical trial evaluating LCAR-AIO for relapsed/refractory systemic lupus erythematosus is currently recruiting.
-
CLINICAL_TRIALS research · 2025-01-08Clinical Trial Update: A Clinical Study of CD19 CAR-T in Active Systemic Lupus Erythematosus [Phase 1, Phase 2]
Clinical trial update on CD19 CAR-T cell therapy being studied in active systemic lupus erythematosus (Phase 1/Phase 2); currently recruitin…
-
CLINICAL_TRIALS research · 2025-01-08Clinical Trial Update: Study of Neonatal IgG Fc Receptor Expression in Natural Killer T Cells Expressing an Invariant T Receptor : Implication in the Pathophysiology of Systemic Lupus
A recruiting clinical study from University Hospital, Tours investigates neonatal IgG Fc receptor expression in invariant NKT cells to under…
-
CLINICAL_TRIALS research · 2024-12-13Clinical Trial Update: A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis [Phase 1]
Amgen's Phase 1 study evaluating VIB7734 in multiple autoimmune diseases including systemic lupus erythematosus, cutaneous lupus erythematos…
-
CLINICAL_TRIALS research · 2024-12-12Clinical Trial Update: Validation of the Lupus Low Disease Activity State (LLDAS) in the Asia Pacific Region
Clinical trial update describing the validation of the Lupus Low Disease Activity State (LLDAS) criteria in the Asia-Pacific region.
-
CLINICAL_TRIALS research · 2024-12-06Clinical Trial Update: Rheumatology Diet Study
A rheumatology dietary intervention study sponsored by the University of Central Florida is currently recruiting, listing multiple autoimmun…
-
CLINICAL_TRIALS research · 2024-12-03Clinical Trial Update: Interleukin23 in Systemic Lupus [NA]
A clinical trial is recruiting at Sohag University to evaluate interleukin-23 in systemic lupus erythematosus with interstitial lung disease…
-
CLINICAL_TRIALS research · 2024-11-27Clinical Trial Update: US Zamto-cel Autoimmune Diseases [Phase 1]
Miltenyi Biomedicine reports a Phase 1 trial of Zamto-cel for autoimmune diseases including lupus nephritis, systemic lupus erythematosus, s…
-
CLINICAL_TRIALS research · 2024-11-20Clinical Trial Update: Universal CAR-T Cells (BRL-301) in Relapse or Refractory Autoimmune Diseases [NA]
A clinical trial update shows BRL-301 universal CAR-T cells from Bioray Laboratories enrolling (by invitation) for relapse or refractory aut…
-
CLINICAL_TRIALS research · 2024-11-19Clinical Trial Update: Safety and Efficacy of Telitacicept in the Treatment of Systemic Lupus Erythematosus (SLE)
This clinical trial update notes the recruitment of participants to study telitacicept for systemic lupus erythematosus, evaluating its safe…
-
CLINICAL_TRIALS research · 2024-11-19Clinical Trial Update: A Study of SYS6020 Injection in Refractory Active Systemic Lupus Erythematosus [Phase 1]
A Phase 1 clinical trial evaluating SYS6020 Injection in patients with refractory active systemic lupus erythematosus; the study status is n…
-
CLINICAL_TRIALS research · 2024-11-15Clinical Trial Update: Efficacy and Safety of CD19 UCAR T Cells in Refractory Systemic Lupus Erythematosus [Phase 1]
A Phase 1 clinical trial evaluating CD19 UCAR T Cells for efficacy and safety in patients with refractory systemic lupus erythematosus; recr…